Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer
- 1 August 2001
- Vol. 58 (2) , 233-239
- https://doi.org/10.1016/s0090-4295(01)01168-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Early Androgen Deprivation for Prostate Cancer?New England Journal of Medicine, 1999
- RADICAL RETROPUBIC PROSTATECTOMY PLUS ORCHIECTOMY VERSUS ORCHIECTOMY ALONE FOR pTxN+ PROSTATE CANCER: A MATCHED COMPARISONJournal of Urology, 1999
- COMBINED ORCHIECTOMY AND EXTERNAL RADIOTHERAPY VERSUS RADIOTHERAPY ALONE FOR NONMETASTATIC PROSTATE CANCER WITH OR WITHOUT PELVIC LYMPH NODE INVOLVEMENT: A PROSPECTIVE RANDOMIZED STUDYJournal of Urology, 1998
- Ten-Year Outcomes for Pathologic Node-Positive Patients Treated in RTOG 75-06International Journal of Radiation Oncology*Biology*Physics, 1998
- Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablationCancer, 1997
- Early Androgen Ablation for Stage D1 (N1 to N3, M0) Prostate Cancer: Prognostic Variables and OutcomeJournal of Urology, 1994
- Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year resultsUrology, 1994
- Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumorsCancer, 1992
- Prognosis of Patients with Stage D1 Prostate Carcinoma Following Radical Prostatectomy with and Without Early Endocrine TherapyJournal of Urology, 1990